Blockade of Receptor for Advanced Glycation End-Products Restores Effective Wound Healing in Diabetic Mice

This publication has 48 references indexed in Scilit:

• Large and Sustained Induction of Chemokines during Impaired Wound Healing in the Genetically Diabetic Mouse: Prolonged Persistence of Neutrophils and Macrophages during the Late Phase of Repair
  Journal of Investigative Dermatology, 2000
• Recombinant human platelet‐derived growth factor‐BB (becaplermin) for healing chronic lower extremity diabetic ulcers: an open‐label clinical evaluation of efficacy
  Wound Repair and Regeneration, 2000
• RAGE Mediates a Novel Proinflammatory Axis: A Central Cell Surface Receptor for S100/Calgranulin Polypeptides
  Published by Elsevier ,1999
• β2-microglobulin modified with advanced glycation end products modulates collagen synthesis by human fibroblasts
  Kidney International, 1998
• Interactions of cytokines, growth factors, and proteases in acute and chronic wounds
  Wound Repair and Regeneration, 1996
• Receptor-mediated endothelial cell dysfunction in diabetic vasculopathy. Soluble receptor for advanced glycation end products blocks hyperpermeability in diabetic rats.
  Journal of Clinical Investigation, 1996
• Advanced glycation endproducts interacting with their endothelial receptor induce expression of vascular cell adhesion molecule-1 (VCAM-1) in cultured human endothelial cells and in mice. A potential mechanism for the accelerated vasculopathy of diabetes.
  Journal of Clinical Investigation, 1995
• Regulation of human mononuclear phagocyte migration by cell surface-binding proteins for advanced glycation end products.
  Journal of Clinical Investigation, 1993
• Abnormalities of Granulation Tissue and Collagen Formation in Experimental Diabetes, Uraemia and Malnutrition
  Diabetic Medicine, 1986
• The influence of age and dietary conditions on diabetes in the db mouse
  Diabetologia, 1970